Evaluating effectiveness of maternal RSV vaccination and nirsevimab for severe RSV-related illness in infants
A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had significantly lower RSV infection and health care use compared to unprotected infants. It also showed fewer severe complications in RSV-positive infants with prevention. Thes
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · health
- [HEALTH] Knowledge, Attitudes, and Practices Regarding Arboviruses at a Human-Wildlife Interface: A Cross-Sectional Study in and
- [HEALTH] How to shore up trust during the "cold-period" between pandemics - closing the public trust gap in pandemic preparedness
- [HEALTH] Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era.
- [HEALTH] Emergency department evaluation and management of serious and high-risk infections in the febrile returning traveler.
- [HEALTH] Trk1 potassium transport is crucial for effective Candidozyma auris skin colonization.
- [HEALTH] [A rapid visual detection method for porcine circovirus type 4 based on enzymatic recombinase amplification and CRISPR/E